Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas
1996

HGF/SF in Non-Small-Cell Lung Carcinomas

Sample size: 42 publication Evidence: moderate

Author Information

Author(s): M Olivero, M Rizzo, R Madeddu, C Casadio, S Pennacchietti, MR Nicotra, M Prat, G Maggi, N Arena, PG Natali, PM Comoglio, MF Di Renzo

Primary Institution: Institute for Cancer Research and Treatment IRCC, University of Torino Medical School

Hypothesis

We postulated that uPA might promote the invasive properties of NSCLC via HGF/SF activation.

Conclusion

HGF/SF is overexpressed and consistently activated in non-small-cell lung carcinomas and may contribute to the invasive growth of lung cancer.

Supporting Evidence

  • HGF/SF was found to be 10 to 100-fold overexpressed in carcinoma samples.
  • The Met/HGF receptor was found to be 2 to 10-fold increased in 25% of carcinoma samples.
  • Immunohistochemical staining showed homogeneous expression of both the receptor and the ligand in carcinoma samples.

Takeaway

This study found that a protein called HGF/SF is much more active in lung cancer than in normal lung tissue, which might help the cancer grow and spread.

Methodology

Tissue samples from 42 patients were analyzed using Western blot analysis to compare HGF/SF and Met/HGF receptor expression in carcinoma and adjacent normal tissues.

Limitations

The study did not allow for statistical analysis of the correlation between overexpression and disease stage.

Participant Demographics

Mean age 65 (range 40-76) years; 37 males and 5 females.

Statistical Information

P-Value

P=0.0113

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication